Drug dispenser giant CVS Caremark (NYSE:CVS) closed out its year by reporting impressive growth in its pharmacy services business. This growth has taken close to five years to achieve, and while the top line trends look encouraging, the total profit growth outlook looks more challenging. Combined with a significant recent stock run, the investment appeal of the stock doesn't currently appear overly healthy.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Full-Year Recap
Sales advanced 11.8% to $107.1 billion. The leading contributor was pharmacy services, or the Caremark pharmacy benefit management (PBM) arm that competes with pure play rivals including Medco Health Solutions (NYSE:MHS) and Express Scripts (Nasdaq:ESRX), which are actually planning to merge and create the dominant PBM player.

Health insurers, including UnitedHealth Group (NYSE:UNH), also operate their own PBM businesses. The PBM segment for CVS posted an impressive 24.9% annual growth. The CVS retail pharmacy, which competes with Rite Aid (NYSE:RAD), reported respectable growth of 3.9% as same-store sales improved 2.3%. Each unit accounted for roughly half of total sales.

The retail pharmacy business is much more profitable and brought in $4.5 billion in profits for the year. In contrast, the PBM side brought in $2.4 in operating income. Total operating income was $6.1 billion. Pre-tax income rose a modest 2.6% to $5.7 billion. Higher income tax expense meant net income rose less than 2% to $3.5 billion. Share buybacks boosted the bottom line a bit more to 3.2% as earnings per diluted share reached $2.57. Free cash flow came in at approximately $2.91 per diluted share. (To know more about income statements, read Understanding The Income Statement.)

For the coming year, CVS expects to report earnings in a range of $2.96 to $3.06. Analysts currently project sales growth of nearly 12% and total sales of almost $120 billion. The company said to expect strong free cash flow production between $4.6 billion and $4.9 billion, or roughly $3.41 and $3.64 per diluted share.

The Bottom Line
CVS shares are bumping up against their highs for the year and currently trade at a forward P/E of about 12. The forward free cash flow multiple is slightly more reasonable at less than 12, but both multiples suggest that much of CVS Caremark's future growth is already discounted in the share price. The PBM business is finally seeing some nice growth trends, which are the first since CVS merged with Caremark in 2007.

However, it looks to be gaining new business with aggressive pricing that could make total company profit growth more difficult to sustain over the long haul. Retailing trends are more steady, but it will be hard for CVS to grow its store count aggressively going forward. (For additional reading, check out 5 Must-Have Metrics For Value Investors.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!

At the time of writing, Ryan C. Fuhrmann did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  2. Stock Analysis

    The Biggest Risks of Investing in Amazon Stock

    Find out which risks are most important to Amazon's shareholders. Learn which operational risks impact share prices and which financial risks affect investors.
  3. Investing

    How to Win More by Losing Less in Today’s Markets

    The further you fall, the harder it is to climb back up. It’s a universal truth that is painfully apparent in the investing world.
  4. Fundamental Analysis

    Use Options Data To Predict Stock Market Direction

    Options market trading data can provide important insights about the direction of stocks and the overall market. Here’s how to track it.
  5. Stock Analysis

    2 Oil Stocks to Buy Right Now (PSX,TSO)

    Can these two oil stocks buck the trend?
  6. Investing News

    What Alcoa’s (AA) Breakup Means for Investors

    Alcoa plans to split into two companies. Is this a bullish catalyst for investors?
  7. Stock Analysis

    Top 3 Stocks for the Coming Holiday Season

    If you want to buck the bear market trend by going long on consumer stocks, these three might be your best bets.
  8. Investing News

    Could a Rate Hike Send Stocks Higher?

    A rate hike would certainly alter the investment scene, but would it be for the better or worse?
  9. Investing News

    This is the Fastest-Growing Consumer Complaint

    There’s no way to guarantee that your Social Security number won’t fall into the wrong hands. Here are some ways to make yourself less of a target.
  10. Investing Basics

    These Industries Have The Most Illiquid Stocks

    U.S. equity markets are vast and highly liquid, but a few sectors have failed to attract substantial capital.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  5. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!